Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation-Reference-Cited by-同舟云学术

Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation

Published:2007-01 Issue:1 Volume:47 Page:121-126
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gonzalez Jaime R.,Baiza-Duran Leopoldo,Quintana-Hau Juan,Tornero-Montaño Ruben,Castaneda-Hernandez Gilberto,Ortiz Mario,Alarcon-Oceguera Felipe,Beltran-Loustaunau Marco,Cortez-Gastelum Marco,Garcidueñas-Mejia Jorge,Gomez-Bastar Pedro,Jimenez-Roman Jesus,Korder-Ortega Vincent,Paczka-Zapata Jose,Torres-Segura Marina,Velasco-Gallegos Gustavo

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. Glaucomatous optic neuropathy;Buskirk;Am J Ophthalmol,1992

2. Medical management of glaucoma;Alward;N Engl J Med.,1998

3. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002

4. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial;Leske;Arch Ophthalmol,2003

5. 56,000 ways to treat glaucoma;Realini;Ophthalmology,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclodextrin-based ocular drug delivery systems: A comprehensive review;Coordination Chemistry Reviews;2023-02

2. Nanotechnology in glaucoma—conceptual and clinical treatment aspects;Nanotechnology in Ophthalmology;2023

3. Aqueous Prostaglandin Eye Drop Formulations;Pharmaceutics;2022-10-09

4. An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival;Journal of Clinical Medicine;2022-05-31

5. Advanced nanodelivery platforms for topical ophthalmic drug delivery;Drug Discovery Today;2021-06